Collaboration to evaluate immunotherapy and antibody combination
28 September, 2018Biotechnology company Immutep has entered into a clinical trial collaboration and supply agreement with Merck and Pfizer.
Antimalarial drug boosted with chemo medicines
24 September, 2018Scientists have found a way to boost the efficacy of the world's most powerful antimalarial drug, in a breakthrough that may overcome antimalarial drug resistance.
Medlab granted a licence to export cannabis
12 September, 2018The licence relates to Medlab Clinical's two cannabis-based medicines — NanaBis and NanaBidial.
STEM superstar on the juggle, the struggle and the joy
06 September, 2018 by Jess Melbourne-ThomasMarine ecologist and ecosystem modeller Jess Melbourne-Thomas is one of two Tasmanians who were named as Science and Technology Australia's Superstars of STEM* in 2017/18. Here she reflects on her passion for marine science and recommends people to apply to the program.
Promising new drug candidate designed to lower cholesterol
06 September, 2018The drug candidate NYX-330 is designed to lower cholesterol levels by inhibiting the action of a protein known as PCSK9.
Injectable migraine treatment approved in Australia
04 September, 2018Aimovig — the first in a new class of long-acting, injectable medications for the prevention of migraine in adults — has been approved for use in Australia.
Specialised Therapeutics unveils new Australian headquarters
27 August, 2018Pharmaceutical company Specialised Therapeutics Australia celebrated its 10th anniversary with a business plan to drive healthcare innovation over the next decade.
Insulin resistance drug instead tackles obesity
24 August, 2018A newly developed drug has been found to prevent mice from depositing and storing fat by increasing their ability to burn fat in skeletal muscle.
Agreement to develop a new class of antibiotics
20 August, 2018WA's Telethon Kids Institute and Boulos & Cooper Pharmaceuticals have signed an agreement to develop what could be the first new class of antibiotics in decades.
Biotech start-up to treat autoimmune diseases with hookworms
17 August, 2018Experimental infection of human subjects with hookworms can protect against the onset of autoimmune diseases, according to newly launched biotech Paragen Bio.
Patient enrolment for Alzheimer's trial close to completion
15 August, 2018Actinogen Medical has announced 75% enrolment in its Phase II clinical trial of Xanamem, its drug candidate for the treatment of mild Alzheimer's disease.
Virbac to distribute new anticancer treatment for dogs
13 August, 2018Animal health company Virbac will market and distribute tigilanol tiglate, an anticancer pharmaceutical from QBiotics, to veterinary markets in the US, the UK and the EU.
Peptide drug could treat liver cancer more effectively
06 August, 2018A novel peptide drug called FFW could potentially stop the development of hepatocellular carcinoma (HCC), or primary liver cancer.
Drugging cancer cells to sleep
03 August, 2018Australian researchers have discovered a new type of anticancer drug that is said to be able to put cancer cells into a permanent sleep.
Could Australia's microbiome contain new antibiotics?
01 August, 2018Industry and academia are coming together in a three-year, $6.9 million quest to search for new antibiotics in 500,000 species of Australian microbes.
